Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lesinurad and Febuxostat Combination Extension Study in Gout
NCT01808144Phase 3Completed
- Sponsor
- Ardea Biosciences, Inc.
- Start
- Mar 2013
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of lesinurad in gout, sponsored by Ardea Biosciences, Inc.. Started Mar 2013; status: completed.
02
Drugs
lesinurad
03
Conditions
gout
Beyond the preview
Go deeper on NCT01808144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01808144.